Genomic and proteomic biomarkers for cancer: a multitude of opportunities
MA Tainsky - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2009 - Elsevier
Biomarkers are molecular indicators of a biological status, and as biochemical species can
be assayed to evaluate the presence of cancer and therapeutic interventions. Through a …
be assayed to evaluate the presence of cancer and therapeutic interventions. Through a …
First‐line therapy for chronic myeloid leukemia: Past, present, and future
C Pavlovsky, H Kantarjian… - American journal of …, 2009 - Wiley Online Library
Abstract The development of Bcr‐Abl tyrosine kinase inhibitors has dramatically changed
the prognosis of patients with newly diagnosed chronic myeloid leukemia (CML). Standard …
the prognosis of patients with newly diagnosed chronic myeloid leukemia (CML). Standard …
Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid …
NAG Lankheet, MJX Hillebrand… - Biomedical …, 2013 - Wiley Online Library
To support pharmacokinetic‐guided dosing in individual patients, a fast and accurate
method for simultaneous determination of anticancer tyrosine kinase inhibitors (TKIs) …
method for simultaneous determination of anticancer tyrosine kinase inhibitors (TKIs) …
Interpreting laboratory results
MR Pincus, NZ Abraham - Henry's Clinical Diagnosis and …, 2011 - books.google.com
Two types of endocrine disease are discussed: Thyroid and adrenal. Serum levels of T4 (or,
better, free T4) and thyroid-stimulating hormone can be used to diagnose primary or …
better, free T4) and thyroid-stimulating hormone can be used to diagnose primary or …
Challenges in the codevelopment of companion diagnostics
MW Moore, D Babu, PD Cotter - Personalized Medicine, 2012 - Taylor & Francis
Therapeutics harnessing the power of personalized medicine have the potential to
revolutionize healthcare. Companion diagnostics are critical to this goal and are …
revolutionize healthcare. Companion diagnostics are critical to this goal and are …
Simultaneous determination of methotrexate, dasatinib and its active metabolite N-deshydroxyethyl dasatinib in rat plasma by LC-MS/MS: method validation and …
SRS Thappali, KVS Varanasi… - …, 2012 - thieme-connect.com
Dasatinib is a multi-kinase inhibitor that potently inhibits Bcr-Abl, Src family and platelet-
derived growth factor receptor kinases. Methotrexate is an antimetabolite and antifolate …
derived growth factor receptor kinases. Methotrexate is an antimetabolite and antifolate …
Gambaran Laboratorium Leukemia Kronik di Bagian Penyakit Dalam RSUP Dr. M. Djamil Padang
M Rendra, R Yaswir, AM Hanif - Jurnal kesehatan andalas, 2013 - jurnal.fk.unand.ac.id
Leukemia merupakan penyakit keganasan sel darah yang berasal dari sumsum tulang
ditandai oleh proliferasi sel-sel darah putih, dengan manifestasi adanya sel-sel abnormal …
ditandai oleh proliferasi sel-sel darah putih, dengan manifestasi adanya sel-sel abnormal …
Molecular diagnosis of hematopoietic and lymphoid neoplasms
D Jevremovic, DS Viswanatha - Hematology/oncology clinics of North …, 2009 - Elsevier
This chapter summarizes the significance and molecular diagnostic detection of genetic
abnormalities commonly associated with hematolymphoid neoplasms. Methodologic …
abnormalities commonly associated with hematolymphoid neoplasms. Methodologic …
Establishment of a conversion factor for the Cepheid GeneXpert BCR-ABL assay
M McNiven, D Talaulikar - Pathology-Journal of the RCPA, 2012 - journals.lww.com
The Cepheid Xpert BCR-ABL Monitor assay (Cepheid, USA) is a CE marked in vitro
diagnostic (IVD) assay designed for monitoring the levels of p210 BCR-ABL fusion …
diagnostic (IVD) assay designed for monitoring the levels of p210 BCR-ABL fusion …
[图书][B] Atlas of Hematologic Neoplasms
T Sun - 2009 - Springer
Hematologic neoplasms are tumors of blood cells. All the blood cells are derived from a
pluripotent stem cell that can differentiate into various cell lineages, including erythrocyte …
pluripotent stem cell that can differentiate into various cell lineages, including erythrocyte …